Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABAX

Abaxis (ABAX) Stock Price, News & Analysis

Abaxis logo

About Abaxis Stock (NASDAQ:ABAX)

Advanced Chart

Key Stats

Today's Range
$83.00
$83.00
50-Day Range
N/A
52-Week Range
$43.66
$83.98
Volume
N/A
Average Volume
167,754 shs
Market Capitalization
N/A
P/E Ratio
42.35
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abaxis and its competitors with MarketBeat's FREE daily newsletter.

ABAX Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
See More Headlines

ABAX Stock Analysis - Frequently Asked Questions

Abaxis, Inc. (NASDAQ:ABAX) issued its quarterly earnings results on Thursday, April, 26th. The medical research company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.10. Abaxis's revenue for the quarter was up 16.7% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abaxis investors own include Skyworks Solutions (SWKS), Wells Fargo & Company (WFC), Bristol Myers Squibb (BMY), Abbott Laboratories (ABT), Allergan (AGN), Akorn (AKRX) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
4/26/2018
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Measuring & Controlling Devices
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ABAX
CIK
881890
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
42.35
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ABAX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners